by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Form 483sForm 483 Details

GlaxoSmithKline Biologicals SA Form 483 Details

Form 483

Source: FDA, document on fileFDA released the Form 483 itself and the document linked above is FDA's own file, served from fda.gov.

To check this against FDA, open FDA's record for this establishment on FDA's Data Dashboard, which lists this inspection under FEI 3003973577.

GlaxoSmithKline Biologicals SA

Issue DateFebruary 27, 2026

FEI Number3003973577

CountryN/A

Status

No Warning Letter

Establishment Type

Vaccine Manufacturer

GlaxoSmithKline Biologicals SA FDA Form 483, February 27, 2026